Tumor Necrosis Factor ± (TNF-±)-induced Cell Adhesion to Human Endothelial Cells Is under Dominant Control of One TNT Receptor Type, TNF-R55

Journal of Experimental Medicine

Volumn 177, Issue 5, 1993, Pages 1277-1286

  Mackay, Fabienne ^a   Loetscher, Hansruedi ^a   Stueber, Dietrich ^a   Gehr, Gisela ^a   Lesslauer, Werner ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE RECEPTOR; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR BINDING; RECEPTOR UPREGULATION;

BASE SEQUENCE; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMAN; INTEGRINS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR; UP-REGULATION;

EID: 0027512562     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.5.1277     Document Type: Article

References (68)

1. Carswell, E.A., L.J. Old, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin induced serum factor that causes necrosis of tumor. Proc. Natl. Acad. Sci. USA. 72:3666.
2. Old, L. 1986. Tumor necrosis factor. Science (Wash. DC). 230:630.
3. Beutler, B., and A. Cerami. 1989. The biology of cachectin/ TNF: a primary mediator of host response. Annu. Rev. Immunol. 7:625.
4. Vassalli, P. 1992. The Pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
5. Pober, J.S., and R.S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427.
6. Mantovani, A., F. Bussolino, and E. Dejana. 1992. Cytokine regulation of endothelial cell function. FASEB (Fed. Am. Soc Exp. Biol.) J. 6:2591.
7. Dosne, A.M., F. Dubor, F. Lutcher, M. Parant, and L. Chedid. 1988. Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decrease blood fibrinolytic activity in the rat. Thrombi Res. 51:115.
8. Nawroth, P.P., I. Bank, D. Handley, J. Cassimeris, L. Chees, and D. Stern. 1986. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp Med. 163:1363.
9. Broudy, V.C., K. Kaushansky, G.M. Segal, J.M. Harlan, and J.W. Adamson. 1986. Tumor necrosis type a stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA. 83:7467.
10. Jirik, F.R., T.J. Fodor, T. Hirano, T. Kishimoto, D.J. Loskutoff, D. A. Carson, and M. Lotz. 1989. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142:144.
11. Henning, B., S.E. Goldblum, and C.J. McClain. 1987. Inter- leukin-1 (IL-1) and tumor necrosis factor/cachectin (TNF) increase endothelial permeability in vitro. J. Leukocyte Biol. 42:551.
12. Bevilacqua, M.P., S. Stengelin, M.A. Gimbrone, and B. Seed. 1989. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (Wash. DC). 243:1160.
13. Pober, J.S., L.A. Lapierre, A.H Stolpen, T.A. Brock, T.A. Springer, W. Fiers, M.P. Bevilacqua, D.L. Mendrick, and M.A. Gimbrone. 1987. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immunol. 138:3319.
14. Osborn, L., C. Hession, R. Tizard, C. Vassallo, S. Luhowskyj, G. Chi-Rosso, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1203.
15. Rice, G.E., and M.P. Bevilacqua. 1989. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science (Wash. DC). 246:1303.
16. Carlos, T.M., B.R. Schwartz, N.L. Kovach, E. Yee, M. Rosso, L. Osborn, G. Chi-Rosso, B. Newman, R. Lobb, and J.M. Harlan. 1990. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 76:965.
17. x determinant on myeloid and tumor cells. Science (Wash. DC). 250:1132.
18. Elices, M.J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M.E. Hemler, and R.R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:577.
19. Marlin, S.D., and T.A. Springer. 1987. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 51:813.
20. Springer, T.A. 1990. Adhesion receptors of the immune system. Nature (Lotid.). 346:425.
21. Loetscher, H., M. Brockhaus, Z. Dembic, R. Gentz, U. Gu-bler, H.P. Hohmann, H.W. Lahm, A.P.G.M. van Loon, Y.C.E. Pan, E.J. Schlaeger, M. Steinmetz, H. Tabuchi, and W. Lesslauer. 1991. Two distinct tumor necrosis factor receptors-members of a new cytokine receptor gene family. In Oxford Surveys on Eukaryotic Genes. N. Maclean, editor. Oxford University Press, Oxford. 119-142.
22. Loetscher, H., R. Gentz, M. Zulauf, A. Lustig, H. Tabuchi, E.J. Schlaeger, M. Brockhaus, H. Gallati, M. Manneberg, and W. Lesslauer. 1991. Recombinant 55 kDa tumor necrosis factor (TNF) receptor. J. Biol. Chem. 266:18324.
23. Flohmann, H.P., M. Brockhaus, P.A. Baeuerle, R. Remy, R. Kolbeck, and A.P.G.M. van Loon. 1990. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-xB. J. Biol. Chem. 265:22409.
24. Dembic, Z., H. Loetscher, U. Gubler, Y.C.E. Pan, H.W. Lahm, R. Gentz, M. Brockhaus, and W. Lesslauer. 1990. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine. 2:231.
25. Loetscher, H., M. Steinmetz, and W. Lesslauer. 1991. Tumor necrosis factor: receptors and inhibitors. Cancer Cells (Cold Spring Harbor). 3:221.
26. Loetscher, H., E.J. Schlaeger, H.W. Lahm, Y.C.E. Pan, W. Lesslauer, and M. Brockhaus. 1990. Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells. J. Biol. Chem. 265:20131.
27. Engelmann, H., H. Holtmann, C. Brakebusch, Y.S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497.
28. Espevik, T., M. Brockhaus, H. Loetscher, U. Nonstad, and R. Shalaby. 1990. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp Med. 171:415.
29. Shalaby, M.R., A. Sundan, H. Loetscher, M. Brockhaus, W. Lesslauer, and T. Espevik. 1990. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp Med. 172:1517.
30. Tartaglia, L.A., and D.V. Goeddel. 1992. Tumor necrosis factor receptor signalling. J. Biol. Chem. 267:4304.
31. Trefzer, U., M. Brockhaus, H. Loetscher, F. Parlow, A. Kapp, E. Schopf, and J. Krutmann. 1991. 55-kD tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J. Invest. Dermatol. 97:911.
32. Kruppa, G., B. Thoma, T. Machleidt, K. Wiegmann, and M. Kronke. 1992. Inhibition of tumor necrosis factor (TNF)-mediated NF-xB activation by selective blockade of the human 55-kDa TNF receptor. J. Immunol. 148:3152.
33. Hohmann, H.P., R. Remy, B. Poschl, and A.P.G.M. van Loon. 1990. Tumor necrosis factors-a and -/3 bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-xB at low receptor occupancy and within minutes after receptor binding. J. Biol. Chem. 265:15183.
34. Tartaglia, L.A., R.F. Weber, I.S. Figari, C. Reynolds, M.A. Palladino, Jr., and D.V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl. Acad. Sci. USA. 88:9292.
35. Vandenabeele, P., W. Declercq, D. Vercammen, M. Van de Craen, J. Grooten, H. Loetscher, M. Brockhaus, W. Lesslauer, and W. Fiers. 1992. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J. Exp Med. 176:1015.
36. Gehr, G., R. Gentz, M. Brockhaus, H. Loetscher, and W. Lesslauer. 1992. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J. Immunol. 149:911.
37. Naume, B., R. Shalaby, W. Lesslauer, and T. Espevik. 1991. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphocyte-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 146:3045.
38. Jaffe, E.A., R.L. Nachman, C.G. Becker, and C.R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:2745.
39. Brockhaus, M., H.J. Schoenfeld, E.J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl. Acad. Sci. USA. 87:3127.
40. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680.
41. Subiza, J.L., J. Gil, J.G. Ruiz de Morales, R. Rodriguez, and E.G. De la Concha. 1991. Some improvements in the reversed centrifugation method for the quantification of cell to cell adhesion. J. Immunol. Methods. 140:127.
42. Digman, J.D., R.M. Lebowitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
43. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:705.
44. Leonardo, M., J.W. Pierce, and D. Baltimore. 1987. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (Wash. DC). 236:1573.
45. Dustin, M.L., R. Rothlein, A.K. Bhan, C.A. Dinarello, and T.A. Springer. 1986. Induction by IL-1 and interferon-y: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:245.
46. Dalchau, R., J. Kirkley, and J.W. Fabre. 1980. Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W3/13 antigen of the rat. Eur. J. Immunol. 10:745.
47. Lapierre, L.A., W. Fiers, and J.S. Pober. 1988. Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. J. Exp Med. 167:794.
48. Conforti, G., A. Zanetti, S. Colella, M. Abbadini, P.C. Marchisio, R. Pytela, F. Giancotti, G. Tarone, L.R. Languino, and E. Dejana. 1989. Interaction of fibronectin with cultured human endothelial cells: characterization of the specific receptor. Blood. 73:1576.
49. Languino, L.R., K.R. Gehlsen, E. Wayner, W.G. Carter, E. Engvall, and E. Ruoslahti. 1989. Endothelial cells use a2/3l integrin as laminin receptor. J. Cell Biol. 109:2455.
50. Kramer, R.H., Y.F. Cheng, and R. Clyman. 1990. Human microvascular endothelial cells use /8l and /33 integrin receptor complexes to attach to laminin. J. Cell Biol. 111:1233.
51. Defilippi, P., C. Bozzo, M. Geuna, P. Rossino, L. Silengo, and G. Tarone. 1992. Modulation of extracellular matrix receptors (integrins) on human endothelial cells by cytokines. In Angiogenesis: Key Principles-Science-Technology-Medicine. R. Steiner, RB. Weisz, and R. Langer, editors, Birkhauser Verlag, Basel. 193-197.
52. Lowenthal, J.W., D.W. Ballard, E. Bohnlein, and W.C. Greene. 1989. Tumor necrosis factor a induces proteins that bind specifically to fcB-like enhancer elements and regulate interleukin 2 receptor a-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA. 86:2331.
53. Osborn, L., S. Kundel, and G.J. Nabel. 1989. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl. Acad. Sci. USA. 86:2336.
54. Collins, T. 1992. Analysis of the ELAM-1 and VCAM-1 promoters-tools to target gene expression in endothelium in transgenic animals. J. Vase Surg. 15:923.
55. Voraberger, G., R. Schaffer, and C. Stratowa. 1991. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. J. Immunol. 145:2777.
56. Montgomery, K.F., L. Osborn, C. Hession, R. Tizard, D. Goff, C. Vassallo, P.I. Tarr, K. Bomsztyk, R. Lobb, J.M. Harlan, and T.H. Pohlman. 1991. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA. 88:6523.
57. Wawryk, S.O., P.N. Cockerill, I.P. Wicks, and A.W. Boyd. 1991. Isolation and characterization of the promoter region of human intercellular adhesion molecule-1 gene. Int. Immunol. 3:83.
58. Iademarco, M.F., J.J. McQuillan, G.D. Rosen, andD.C. Dean. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:16323.
59. Israel, A., O. Le Bail, D. Hatat, J. Piette, M. Kieran, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky. 1989. TNF stimulates expression of mouse MHC class I genes by inducing an NF-fcB-like enhancer binding activity which displaces constitutive factors. EMBO (Eur. Mol. Biol. Organ.) J. 8:3793.
60. Shimizu, Y., W. Newman, Y. Tanaka, and S. Shaw. 1992. Lymphocyte interactions with endothelial cells. Immunol. Today. 13:106.
61. Shimizu, Y., W. Newman, TV. Gopal, K.J. Horgan, N. Graber, L.D. Beall, G.A. van Seventer, and S. Shaw. 1991. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions./ Cell Biol. 113:1203.
62. Thorp, K.M., C. Southern, I.N. Bird, and N. Matthews. 1992. Tumor necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells-Analysis of tumor necrosis factor-receptor interactions. Cytokine. 4:313.
63. Hynes, R.O.1992. Integrins: versatility, modulation, and signalling in cell adhesion. Cell. 69:11.
64. Santala, P., and J. Heino. 1991. Regulation of integrin-type cell adhesion receptors by cytokines. J. Biol. Chem. 266:23505.
65. Defilippi, P., G. Truffa, G. Stefanuto, F. Altruda, L. Silengo, and G. Tarone. 1991. Tumor necrosis factor a and interferon y modulate the expression of the vitronectin receptor (inte-grin 03) in human endothelial cells. J. Biol. Chem. 266:7638.
66. Defilippi, P., L. Silengo, and G. Tarone. 1992. a6.01 integrin (laminin receptor) is down-regulated by tumor necrosis factor a and interleukin-1 0 in human endothelial cells. J. Biol. Chem. 267:18303.
67. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zôller, I. HauBmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:13.
68. Haynes, B.F., M.J. Telen, L.P. Hale, and S.M. Denning. 1989. CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunol. Today. 10:423.